Innovation Theater
Use of a Prescription Janus Kinase (JAK) Inhibitor for Active Ankylosing Spondylitis (AS), Including Review of a Hypothetical Patient Case
Exhibit Hall, Innovation Theater A
Developed and offered by Pfizer, Inc.
(Non-CME)